Christopher Heeschen (born 1966) is a German MD with a PhD.[1] In 2004, he became a professor of Experimental Medicine and Department Head of Medicine at the University of Munich.[1] He subsequently held leadership positions at the Spanish National Cancer Research Centre (CNIO) from 2009 - 2014.[1] and Barts Cancer Institute in London from 2013 - 2018. Since 2018 he is co-director of the Center for Single-Cell Omics at Shanghai Jiao Tong University School of Medicine. In 2021 he also became Principal Investigator at the Candiolo Cancer Institute FPO IRCCS in Italy.[2]
Heeschen was recognized by the Paul-Martini-Award in 2002 for describing a rebound phenomenon in patients with unstable coronary heart disease after the withdrawal of statins.[3] In 2009, he received the Ritzenhain Award from the German Cancer Research Center.[4]
His most cited article, on cancer stem cells,[5] has been cited 3521 times, according to Google Scholar.[6]
References
edit- ^ a b c "Stem Cells and Cancer Group. Biosketch: Christopher Heeschen". CNIO. Retrieved 14 November 2013.
- ^ "LinkedIn Christopher Heeschen". Linkedin. Retrieved 15 April 2024.
- ^ "Paul-Martini-Stiftung / Paul-Martini-Preis 2002". Archived from the original on 2014-07-15. Retrieved 2012-04-12.
- ^ Heidelberg – DKFZ vergibt Richtzenhain-Preis - Metropolregion Rhein-Neckar News
- ^ Hermann, Patrick C.; Huber, Stephan L.; Herrler, Tanja; Aicher, Alexandra; Ellwart, Joachim W.; Guba, Markus; Bruns, Christiane J.; Heeschenemail, Christopher (2007). "Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer". Cell Stem Cell. 1 (3): 313–323. doi:10.1016/j.stem.2007.06.002. PMID 18371365.
- ^ Google Scholar author page